Archive
-
Working Paper
Working Paper SeriesPricing for Medicine Innovation: A Regulatory Approach to Support Drug Development and Patient Access
Feb 2022
US regulators can step in to ensure drug pricing both supports patient access and drug development
-
Working Paper
Working Paper SeriesProfits, Innovation and Financialization in the Insulin Industry
Apr 2020
This paper considers the relationship between profits realized from higher insulin list prices, pharmaceutical innovation, and the financial structures of the three dominant insulin manufacturing companies, which set list prices.
-
Working Paper
Working Paper SeriesFirm-Level Exposure to Epidemic Diseases: Covid-19, SARS, and H1N1
Apr 2020
As Covid-19 spreads globally in the first quarter of 2020, this paper finds that firms’ primary concerns relate to the collapse of demand, increased uncertainty, and disruption in supply chains
-
Working Paper
Working Paper SeriesPrivate Equity Buyouts in Healthcare: Who Wins, Who Loses?
Mar 2020
Private equity firms have become major players in the healthcare industry. How has this happened and what are the results?